MMCM
MDT icon

Murphy & Mullick Capital Management’s Medtronic MDT Stock Holding History

Murphy & Mullick Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61.2K Buy
781
+3
+0.4% +$242 0.04% 273
2026
Q1 		$67.4K Buy
778
+3
+0.4% +$287 0.05% 250
2025
Q4 		$74.4K Buy
775
+1
+0.1% +$97 0.05% 229
2025
Q3 		$70.4K Buy
774
+8
+1% +$735 0.05% 236
2025
Q2 		$66.8K Sell
766
-43
-5% -$3.65K 0.05% 234
2025
Q1 		$72.7K Buy
809
+4
+0.5% +$358 0.07% 215
2024
Q4 		$64.7K Buy
+805
New +$69.7K 0.06% 226

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Murphy & Mullick Capital Management's MDT Position: Q2 2026 in Review

Murphy & Mullick Capital Management increased its Medtronic (MDT) stake by 0.39% in Q2 2026, buying an estimated $242 and bringing the position to 781 shares worth $61.2K. The position accounts for 0.04% of the portfolio, ranked #273.

Murphy & Mullick Capital Management first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. The position peaked at $74.4K in Q4 2025. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Murphy & Mullick Capital Management held 781 shares of Medtronic worth $61.2K as of Q2 2026.
  • Murphy & Mullick Capital Management bought 3 Medtronic shares in Q2 2026, an estimated $242.
  • Medtronic made up 0.04% of Murphy & Mullick Capital Management's portfolio in Q2 2026, its #273 holding.
  • Murphy & Mullick Capital Management first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
  • Murphy & Mullick Capital Management's Medtronic position peaked at $74.4K in Q4 2025.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.